| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |